Single low-dose primaquine for malaria control in Africa: a systematic review of safety, efficacy and implementation barriers
Since 2012, the WHO has recommended a single low dose of primaquine (SLDPQ, 0.25 mg/kg) alongside artemisinin-based combination therapies (ACTs) to block Plasmodium falciparum transmission and combat artemisinin resistance. Despite its proven benefits, SLDPQ adoption in African malaria policies rema...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/10/8/e020264.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|